Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 1,124
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

1,124 results for “healthy” Back to intelligence hub

Search results

Page 23 of 47
  1. ION547

    IONIS PHARMACEUTICALS INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  2. ION904

    IONIS PHARMACEUTICALS INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  3. IONIS FXI-LRx

    IONIS PHARMACEUTICALS INC

    Healthy Participants

    phase 1 small molecule completed

    1 trial
  4. IONIS-ENaCRx

    IONIS PHARMACEUTICALS INC

    Healthy Subjects

    phase 1 small molecule completed

    1 trial
  5. IP

    Nurix Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  6. ITI-333

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials
  7. IVIb

    CUMBERLAND PHARMACEUTICALS INC

    Healthy

    phase 1 small molecule completed

    1 trial
  8. IW-1701

    Cyclerion Therapeutics

    Healthy

    phase 1 small molecule completed

    2 trials
  9. IW-1973

    Cyclerion Therapeutics

    Healthy

    phase 1 small molecule completed

    2 trials
  10. IW-3300

    IRONWOOD PHARMACEUTICALS INC

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials
  11. Indacaterol (QAB149)

    Novartis Pharmaceuticals

    Healthy

    phase 1 small molecule completed

    1 trial
  12. Infacort

    NEUROCRINE BIOSCIENCES INC

    Healthy Subjects

    phase 1 small molecule completed

    1 trial
  13. Insulin Peglispro

    Eli Lilly and Company

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  14. Interferon beta-1a

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Subjects

    phase 1 mab completed

    1 trial
  15. Ionis AGT-LRx

    IONIS PHARMACEUTICALS INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  16. J2S-MC-GZML

    Eli Lilly Co.

    Healthy, Hepatic Insufficiency

    phase 1 other active

    1 trial
  17. J6B-MC-YKAA

    Eli Lilly Co.

    Healthy, Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

    phase 1 other active

    1 trial
  18. JADE101

    Jade Biosciences

    Healthy Volunteers

    phase 1 small molecule active

    1 trial
  19. JADE101

    Jade Biosciences

    Healthy Volunteers (HV)

    phase 1 small molecule active

    1 trial
  20. JZP047

    Jazz Pharmaceuticals Ireland Limited

    Healthy Participants

    phase 1 small molecule active

    1 trial
  21. JZP441

    Jazz Pharmaceuticals Ireland Limited

    Healthy Participants

    phase 1 small molecule completed

    2 trials
  22. KAI-9531

    Kailera Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  23. KNX100

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial
  24. KPL-404

    Kiniksa Pharmaceuticals International, plc

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.